CME/CE

Jointly provided by UK HealthCare CECentral and DKBmed, LLC. 

Acknowledgement

This activity is supported by an educational grant from Lilly.​ 

Educational Objectives

  • Describe the variation in AD prevalence across race, gender, and other demographic factors.​ 
  • Identify and interpret emerging diagnostic tools that can facilitate earlier and more accurate diagnosis of AD.​ 
  • Evaluate clinical appropriateness of available disease-modifying treatments for AD.​ 
  • Apply best practices for communicating about dementia and screening for AD with patients and caregivers, with sensitivity to cultural, emotional, and systemic barriers. 

Disclosures

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 

Name of Faculty or Presenter​​​ Reported Financial Relationship​​​
Gregory Jicha​ Contact Research: AbbVie, Cassava, Cognition Therapeutics, Eisai, Novo Nordisk, Vivoryon​
Paid Speaker for CME: Medscape​
Protocol Consultant: IQVIA​
Frederick Schmitt​ No related conflicts with funding from NIH grants to the University of Kentucky.​

Available Credit

1.00 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

This Enduring activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

1.00 ANCC (UK Healthcare CECentral)
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour(s).

1.00 Participation
UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.  

There are no fees for participating and receiving CME/CE credit for this activity.  

Request for Credit

If you wish to receive acknowledgment for completing this activity, please complete the evaluation.  

  • Release date: 9/30/25 
  • Expiration date: 9/29/26 

Estimated time to complete the activity: 60 minutes 

Hardware & Software Requirements

To access activities, users will need:   

  • A computer with an internet connection   
  • An HTML5 compliant web browser or Internet Explorer 8 (and higher)   

Contact Information 

For additional information about the accreditation of this activity, please visit CE Central